Related references
Note: Only part of the references are listed.Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon α-2B for reducing recurrence of superficial bladder cancer
Fadi N. Joudi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer
M Nogawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Bacillus Calmete-Guerin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity
JS Lam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2003)
Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder:: A Nordic study
E Kaasinen et al.
EUROPEAN UROLOGY (2003)
Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer
Zhangqun Ye et al.
CURRENT MEDICAL SCIENCE (2001)
Share Paper
